eganelisib
Generic: IPI-549·Code: IPI-549
eganelisib: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| INFINITY PHARMACEUTICALS, INC. (INFI) | Phase 2 |
Get deeper analysis on eganelisib
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis